# A phase 2b, randomized, double-blind, placebo-controlled, clinical trial of atacicept for treatment of IgA nephropathy

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/a-phase-2b-randomized-double-blind-placebo-controlled-clinical-trial-of/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Richard Lafayette,Sean Barbour,Rubeen Israni,Xuelian Wei,Necmi Eren,Jürgen Floege,Vivekanand Jha,Sung Gyun Kim,Bart Maes,Richard Phoon,Harmeet Singh,Vladimı́r Tesař,Celia J. F. Lin,Jonathan Barratt |
| Citations | 125 |
| DOI | 10.1016/j.kint.2024.03.012 |
| Fields | Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | http://www.kidney-international.org/article/S0085253824002369/pdf |
| OpenAlex ID | https://openalex.org/W4393238164 |
| PMID | 38552841 |
| Type | article |
| Year | 2024 |

## Paper authors

- [Sean Barbour](https://scholariq.org/researchers/sean-barbour/)

## Paper journal

- [Kidney International](https://scholariq.org/journals/kidney-international/)

## Paper primary topic

- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)

## Paper topics

- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)
- [Autoimmune Bullous Skin Diseases](https://scholariq.org/topics/autoimmune-bullous-skin-diseases/)
- [Systemic Lupus Erythematosus Research](https://scholariq.org/topics/systemic-lupus-erythematosus-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.